Abbott Laboratories (LON:0Q15)

London · Delayed Price · Currency is GBP · Price in USD

124.83

-0.56 (-0.45%)

At close: Dec 4, 2025

7.47% (1Y)

Market Cap	163.25B
Revenue (ttm)	32.62B
Net Income (ttm)	10.36B
Shares Out	n/a
EPS (ttm)	5.92
PE Ratio	15.76
Forward PE	22.38
Dividend	1.81 (1.45%)
Ex-Dividend Date	Oct 15, 2025

Volume	4,324
Average Volume	3,087
Open	125.66
Previous Close	125.39
Day's Range	124.09 - 126.26
52-Week Range	105.68 - 141.41
Beta	0.66
RSI	42.87
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus

Founded 1888

Employees 114,000

Stock Exchange London Stock Exchange

Ticker Symbol 0Q15

Full Company Profile

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD Financial Statements

News

There is no news available yet.